Overcoming Challenges in CAR T-cell Product CGMP Release

Mol Ther. 2016 May;24(5):845-6. doi: 10.1038/mt.2016.72.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Humans
  • Immunotherapy, Adoptive
  • Neoplasms / therapy*
  • Receptors, Antigen, T-Cell / therapeutic use*
  • T-Lymphocytes / cytology*

Substances

  • Antineoplastic Agents
  • Receptors, Antigen, T-Cell